Preventive effect of metronidazole vaginal tablets on vaginal bacteria-related postoperative complications with total laparoscopic hysterectomy

• Published in: Journal of medical case reports Vol. 17; no. 1; p. 47
• Main Authors: Okamura, Asuka, Isono, Wataru, Tsuchiya, Akira, Honda, Michiko, Saito, Ako, Tsuchiya, Hiroko, Matsuyama, Reiko, Fujimoto, Akihisa, Nishii, Osamu
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 14.02.2023; BioMed Central; BMC
• Subjects: Abdomen; Analysis; Antibiotics; Bacteria; Blood & organ donations; Blood transfusions; Body mass index; Case reports; Complications; Complications and side effects; Confounding (Statistics); Disinfection & disinfectants; Female; Fibroids; Gynecology; Health aspects; Hospitals; Humans; Hysterectomy; Hysterectomy - adverse effects; Hysterectomy - methods; Infections; Laparoscopic surgery; Laparoscopy; Laparoscopy - adverse effects; Laparoscopy - methods; Magnetic resonance imaging; Medical records; Menstruation; Metronidazole; Metronidazole - therapeutic use; Metronidazole vaginal tablet; Multivariate analysis; Patients; Postoperative Complications - etiology; Postoperative Complications - prevention & control; Retrospective Studies; Retrospective study; Surgery; Total laparoscopic hysterectomy; Uterus; Vagina; Vaginal bacteria-related postoperative complications; Vaginal Creams, Foams, and Jellies; Women; Japan; Vaginal bacteria-related postoperative complications; Retrospective study; Total laparoscopic hysterectomy; Metronidazole vaginal tablet; Multivariate analysis
• ISSN: 1752-1947; 1752-1947
• DOI: 10.1186/s13256-023-03789-1

The use of total laparoscopic hysterectomy is increasing. However, as with conventional abdominal hysterectomy, vaginal bacteria-related postoperative complications need to be managed in total laparoscopic hysterectomy. Therefore, we started to combine metronidazole vaginal tablets with intravenous administration of cephem antibiotics immediately before starting surgery to reduce complications. To evaluate the effect of this combination, and to determine the risk factors for these complications, we retrospectively collected medical records from our hospital and performed a multivariate analysis. We reviewed the medical records of 520 patients who underwent total laparoscopic hysterectomy from 1 January 2015 to 31 December 2021. Among these cases, we identified 16 cases as having vaginal bacteria-related postoperative complications, defined as needing more than one additional day for treatment of postoperative complications, namely postoperative infection (10 cases) and vaginal dehiscence (6 cases). First, we evaluate the effect of metronidazole vaginal tablets by dividing the patients into two groups according to whether metronidazole vaginal tablets were used, and comparing the vaginal bacteria-related postoperative complication rates and other indices. Second, we performed a multivariate logistic regression analysis to assess the influence of each of 17 representative factors, including patient characteristics and symptoms, uterus and leiomyoma sizes, concomitant procedures such as laparoscopic cystectomy and pelvic lymphadenectomy, and others. In the multivariate analysis of the 520 cases, we confirmed that the use of metronidazole vaginal tablets could reduce the vaginal bacteria-related postoperative complications rate by more than half (odds ratio, 0.36). In addition to metronidazole vaginal tablets use, concomitant laparoscopic cystectomy and blood transfusion were associated with significant increases in the vaginal bacteria-related postoperative complication rate. The effect of the addition of metronidazole vaginal tablets to pre- and postsurgical treatment on the reduction of vaginal bacteria-related postoperative complications was confirmed. This easy, safe, and low-cost method may improve the management of total laparoscopic hysterectomy.